IP Library Granted Patent US 9,296,631
Granted Patent B2
US 9,296,631 · App. 12/492,825 · Granted Mar 29, 2016

Preparation of environmentally acceptable scale inhibitors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,296,631
App. No.
12/492,825
Granted
Mar 29, 2016
Kind
B2
Abstract

Alkyl phosphonates prepared from amino acids suitable for use in inhibiting scale. The phosphonates are obtained as reaction mixtures where the level of alkyl phosphonation is deliberately controlled to provide only partial alkyl phosphonation of the amino acid. The resulting alkyl phosphonates exhibit improved environmental properties compared to the fully substituted species, while still exhibiting acceptable efficacy in the control of scale. The compositions possess advantages over existing phosphonates in that they exhibit higher biodegradation by method OECD 306. They also offer lower toxicity to marine life compared to the fully substituted species and are not expected to bioaccumulate.

Claims (27)

1. A method of inhibiting scale, comprising:

contacting an aqueous fluid with a scale inhibitor component in an amount effective to inhibit scale, wherein the scale inhibitor component includes at least one alkyl phosphonated amino acid species that comprises greater than 50 weight percent partially substituted, di-alkyl phosphonated amino acid species, and wherein the scale inhibitor component demonstrates greater than about 20% biodegradation in 28 days.

2. The method of claim 1 , wherein the di-substituted alkyl phosphonated amino acids species includes an amino acid functionality having four or more active hydrogen.

3. The method of claim 2 , wherein the amino acid functionality is synthetic.

4. The method of claim 2 , wherein the amino acid functionality is selected from the group consisting of arginine, asparagine, glutamine, histidine, lysine, tryptophan, and combinations thereof.

5. The method of claim 2 , wherein the amino acid functionality is lysine.

6. The method of claim 1 , wherein the alkyl phosphonated amino acid species are methyl phosphonated amino acid species.

7. The method of claim 1 , wherein the scale inhibitor demonstrates greater than about 40% biodegradation in 28 days.

8. The method of claim 1 , wherein the scale inhibitor demonstrates greater than about 40% biodegradation in 63 days.

9. The method of claim 1 , wherein the scale inhibitor demonstrates greater than about 60% biodegradation in 63 days.

10. The method of claim 5 , wherein the at least one alkyl phosphonated lysine species includes greater than 60 weight percent di-substituted alkyl phosphonated lysine.

11. The method of claim 1 , wherein the scale inhibitor component has greater biodegradability than a scale inhibitor component including greater than 50 weight percent of a fully-substituted alkyl phosphonated amino acid.

12. The method of claim 1 , wherein the at least one alkyl phosphonated amino acid species is in the salt form.

13. The method of claim 12 , wherein the at least one alkyl phosphonated amino acid species forms a salt with sodium, potassium, ammonia, monoethanolamine, or combinations thereof.

14. The method of claim 1 , wherein the at least one alkyl phosphonated amino acid species is in the acid form.

15. The method of claim 1 , wherein the amount effective to inhibit scale establishes a concentration between 1 ppm and 100 ppm in the aqueous fluid.

16. The method of claim 5 , wherein the lysine is L-lysine.

17. The method of claim 1 , wherein the scale inhibitor is formulated with additives for use in an application selected from oilfield streams, industrial water treatment, laundry, detergents, industrial cleaning, residential cleaning and medical.

18. The method of claim 1 , wherein the step of contacting includes controllably adding an aqueous solution having the scale inhibitor dissolved therein through a small diameter tube positioned within a well bore in fluid communication with a subterranean formation.

19. The method of claim 1 , wherein the at least one alkyl phosphonated amino acid species includes two or more methyl phosphonated lysine species.

20. The method of claim 1 , wherein the at least one alkyl phosphonated amino acid species comprises at least one methyl phosphonated lysine species including greater than about 50 weight percent di-substituted methyl phosphonated lysine.

21. The method of claim 20 , wherein the scale inhibitor demonstrates greater than about 40% biodegradation in 28 days.

22. The method of claim 20 , wherein the scale inhibitor demonstrates greater than about 60% biodegradation in 28 days.

23. The method of claim 20 , wherein the scale inhibitor demonstrates greater than about 60% biodegradation in 63 days.

24. The method of claim 20 , wherein the at least one methyl phosphonated lysine species is in the form of a salt prepared by reacting the reaction mixture with monovalent cations, divalent cations, nitrogen containing species, or combinations thereof.

25. The method of claim 20 , where the at least one methyl phosphonated lysine species is used for the control of scale in aqueous oilfield fluid.

26. The method of claim 20 , wherein the at least one methyl phosphonated lysine species is used for the control of scale in aqueous fluids associated with applications selected from the group consisting of industrial waste water, laundry, detergents, industrial cleaning and household cleaning.

Assignments (8)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jul 17, 2025
From: JPMORGAN CHASE BANK, N.A.
To: CHAMPIONX LLC; APERGY ESP SYSTEMS, LLC; APERGY BMCS ACQUISITION CORP; HARBISON-FISCHER, INC.; NORRIS RODS, INC.,; NORRIS RODS, INC.,; NORRISEAL-WELLMARK, INC.; PCS FERGUSON, INC.; QUARTZDYNE, INC.; US SYNTHETIC CORPORATION
Reel/Frame 072004/0019 →
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2022
From: BANK OF AMERICA, N.A.
To: CHAMPIONX USA INC.
Reel/Frame 060304/0267 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2020
From: ECOLAB USA INC.
To: CHAMPIONX USA INC.
Reel/Frame 053849/0537 →
SECURITY INTEREST Recorded Jun 5, 2020
From: CHAMPIONX USA INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 052848/0368 →
SECURITY INTEREST Recorded Jun 5, 2020
From: CHAMPIONX USA INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 053250/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2014
From: NALCO COMPANY
To: ECOLAB USA INC.
Reel/Frame 033424/0803 →
MERGER Recorded Jul 30, 2014
From: CHAMPION TECHNOLOGIES, INC.
To: NALCO COMPANY
Reel/Frame 033424/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2009
From: BODNAR, SCOT H.; MILES, ANDREW FREDERICK; FISHER, HENRY C.; SITZ, CURTIS D.
To: CHAMPION TECHNOLOGIES, INC.
Reel/Frame 023123/0448 →